London, UK (PRWEB UK) 17 April 2014
InferMed is pleased to announce its inclusion as a Lot 1 solution provider within the GP Systems of Choice (GPSoC) Framework. Lot 1 status covers the provision of centrally funded GP Clinical IT system functionality, support and hosting. For the first time Arezzo Pathways has a route to becoming available to GP practices in England with funding support from GPSoC.
GPSoC has successfully delivered a flexible mechanism for contracting clinical IT systems in GP practices since 2007, and at present, over 75% of practices use a system provided through the framework, delivering functionality in line with a common set of standards and performance measures that all suppliers must support.
The new framework is geared towards helping practices get the best out of their GP clinical IT systems and includes funding for new key services such as clinical decision support. Lot 1 status means that practices will be able to choose the services they require from those available with license and support costs met by central funding; they will also be able to procure additional services from Lot 1 suppliers using local budgets.
Arezzo Pathways is a web-based service that combines best practice clinical guidelines, including those developed by the National Institute of Clinical Excellence (NICE), with GP clinical system data to generate, at the point of care, recommendations specific to each patient and compliant with the guidelines. This assists clinicians in managing patients especially those with long-term conditions, and in making timely and appropriate referrals.
Duane Lawrence, CEO of InferMed, commented, “InferMed is delighted to be awarded the contract on the new GPSoC framework. We look forward to working in partnership with the principal GP clinical IT system suppliers and to providing Arezzo Pathways to CCGs and GP practices through the GPSoC contracting process.”
The Health and Social Care Information Centre (HSCIC) was established on April 1, 2013 as an Executive Non Departmental Public Body (ENDPB). It is England’s trusted data source, delivering high quality information and IT systems to drive better patient services, care and outcomes. Its work includes publishing more than 220 statistical publications annually; providing a range of specialist data services; managing informatics projects and programmes and developing and assuring national systems against appropriate contractual, clinical safety and information standards.
Since 1999, InferMed has provided software and services to support best practice in medicine. Through its MACRO EDC application and Arezzo® decision support technology, patients receive safe, up-to-date medical treatment based on best available clinical evidence. InferMed solutions tame the volume and complexity of clinical information, transforming it into actionable knowledge, available at the point of care for clinicians in research and practice, and to patients in their homes. InferMed solutions are accessed over a million times per month across Europe, North America and Australasia.
In April 2012 InferMed won a prestigious Queen’s Award for Enterprise in Innovation for its work in developing and commercialising decision support systems for healthcare using its Arezzo Clinical Decision Support technology. The Queen’s Award acknowledged the growing vital role played by Arezzo in encouraging the consistent use and development of good practice, helping to raise standards of clinical care and ensuring that medicine is right first time, every time.
If you would like more information on this release, please contact Mark Snell at InferMed Ltd on 07500 893063 or at mark.snell(at)infermed(dot)com.